A Study to Assess the Incidence of Deep Vein Thrombosis (DVT) Following Prophylactic Intravenous Administration of Recombinant Human Antithrombin(rhAT) to Hereditary Antithrombin (AT) Deficient Patients in High Risk Situations.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Antithrombin alfa (Primary)
- Indications Deep vein thrombosis
- Focus Registrational; Therapeutic Use
- Sponsors rEVO Biologics
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History